Povidone-iodine

Povidone-iodine (PVP-I), a wɔsan nso frɛ no iodopovidone, yɛ aduro a wɔde sa honam ani yadeɛ berɛ a wɔrebɛyɛ oprehyɛn anaa wɔayɛ operehyɛn no awie. ^[1]Ayarehwɛfoɔ tumi de hohoro wɔn nsa ho ma ɛho te. Wɔtumi nso de sa ɔyarefoɔ bi honam ani yadeɛ. Wɔbɛtumi nso de asa ekuro nketewa nso. Wɔtumi yɛ no nku a wɔde sera anaa pawoda.^[2]

Nsunsuansoɔ

Ɛso nsunsuansoɔ no bi ne sɛ, ɛtumi ma obi honam ani hyehye no anaasɛ ɛtumi ma honam no ani baabi hono.^[1] Sɛ wɔde yɛ ekuro a ɛso ho adwuma a, deɛ ekuro atu no no tumi nya berɛboɔ ho haw, , high blood sodium, ne metabolic acidosis.^[1] Ɛnyɛ mma apemfoɔ a wɔn nyafunu no nni mmoroo naawɔtwe aduasa mmienu(32 weeks).^[3] Ɛnyɛ mma wɔn a wɔwɔ thyroid ho haw no nso sɛ wɔbɛfa atoatoa so.^[3]

Nneɛma a ɛkeka bobom yɛ Povidone-iodine ne povidone, hydrogen iodide, ɛma elemental iodine.^[4] Povidone a ɛwɔ mu no yɛ ɔha nkyekyɛmu du.

Abakɔsɛm

Wɔde Povidone-iodine baa dwa so wɔ afe apem, ahankron ne aduonum nnum(1955).^[5] It is on the World Health Organization agye ato mu sɛ ɛka nnuro a ɛho hia pa ara no ho .^[6] Povidone-iodine nyɛ na wɔ mmeaeɛ a wɔtɔn nnuro.^[7] Edin a wɔde nim no wɔ dwa so no bi ne Betadine.^[3]

Beaeɛ a Menyaa Mmoa Firiiɛ

↑ ^1.0 ^1.1 ^1.2 World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 321–323. hdl:10665/44053. ISBN 978-92-4-154765-9.
↑ "Povidone iodine topical". drugs.com. Retrieved 11 May 2024.
↑ ^3.0 ^3.1 ^3.2 British National Formulary (BNF), 69th Edition. British Medical Association; Joint Formulary Committee. 6 March 2015. p. 840. ISBN 978-0-85711-156-2. OCLC 1031488649. Archived from the original on 22 February 2022.
↑ Encyclopedia of polymer science and technology (3rd ed.). Wiley Publishing. 16 October 2013. p. 728. ISBN 978-0-470-07369-8. OCLC 899175361. Archived from the original on 2017-01-13.
↑ Sneader W (31 October 2005). Drug Discovery: A History (in English). John Wiley & Sons. p. 68. ISBN 978-0-470-01552-0. OCLC 62301847. Archived from the original on 2017-01-13.
↑ World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
↑ "Povidone/iodine solution: Indications, Side Effects, Warnings - Drugs.com". www.drugs.com. Archived from the original on 13 January 2017. Retrieved 11 January 2017.

[WHO2008-1] 1.0 ^1.1 ^1.2 World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. pp. 321–323. hdl:10665/44053. ISBN 978-92-4-154765-9.

[2] "Povidone iodine topical". drugs.com. Retrieved 11 May 2024.

[BNF69-3] 3.0 ^3.1 ^3.2 British National Formulary (BNF), 69th Edition. British Medical Association; Joint Formulary Committee. 6 March 2015. p. 840. ISBN 978-0-85711-156-2. OCLC 1031488649. Archived from the original on 22 February 2022.

[En2013-4] Encyclopedia of polymer science and technology (3rd ed.). Wiley Publishing. 16 October 2013. p. 728. ISBN 978-0-470-07369-8. OCLC 899175361. Archived from the original on 2017-01-13.

[5] Sneader W (31 October 2005). Drug Discovery: A History (in English). John Wiley & Sons. p. 68. ISBN 978-0-470-01552-0. OCLC 62301847. Archived from the original on 2017-01-13.

[WHO22nd-6] World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

[7] "Povidone/iodine solution: Indications, Side Effects, Warnings - Drugs.com". www.drugs.com. Archived from the original on 13 January 2017. Retrieved 11 January 2017.

[1]

[2]

[3]

[4]

[5]

[6]

[7]